ÂÜÀòÂÒÂ×

Jamal Nofal currently serves as the Chairman of the Board at Spectra Group and as Chief Executive Officer at Biomed Pharma and ALSHAMELAH FOR TRADE, overseeing financial operations and organizational goals across these companies. Additionally, Jamal holds the position of Chairman at TECHNOMED UNIVERSAL, setting strategic initiatives for the company. As the Business Owner of Yashfeen pharmaceutical group and a former General Manager at both Bestcure Corp and Yashfeen pharma group, Jamal has extensive experience in the pharmaceutical industry, having represented international manufacturers in Yemen. Jamal's career began at Roche Pharmaceuticals, progressing through various roles in oncology and virology. Jamal holds an MBA from the University of Malaya and degrees in pharmacology and pharmacy from Sana'a University.